Related Experiment Video
Updated: Jun 26, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Cardiac manifestations of HIV infection: an African perspective
Mpiko Ntsekhe1, Bongani M Mayosi
1Division of Cardiology at Groote Schuur Hospital, Cape Town, South Africa. mpiko.ntsekhe@uct.ac.za
Insights
HIV-associated heart disease varies globally. In sub-Saharan Africa, tuberculosis and cardiomyopathy dominate, while coronary artery disease is prevalent in industrialized nations due to differing access to highly active anti-retroviral therapy (HAART).
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Cardiac disease is a significant concern for individuals with HIV.
- The specific cardiac manifestations differ based on geographical location and access to treatment.
Purpose of the Study:
- To review the cardiac manifestations of HIV in sub-Saharan Africa.
- To highlight the influence of geography and highly active anti-retroviral therapy (HAART) on HIV-related heart disease.
Main Methods:
- Review of observational data.
- Analysis of epidemiological patterns of HIV-associated cardiac conditions.
Main Results:
- In sub-Saharan Africa, pericardial tuberculosis and cardiomyopathy are dominant due to endemic tuberculosis and limited HAART access.
- In industrialized nations, coronary artery disease is more common, linked to widespread HAART availability.
- HAART appears to reduce the incidence of myopericardial disease and pulmonary hypertension by preserving immune function.
Conclusions:
- Geographical factors and HAART access critically shape the landscape of HIV-related heart disease.
- Prevention and treatment strategies for HIV-related heart disease in developing countries should prioritize universal HAART access.
- Further research is needed to optimize vascular disease reduction strategies in HIV patients in industrialized nations.
Abstract:
The pericardium, myocardium, coronary arteries and pulmonary arteries are the main targets for cardiac disease in people who are infected with HIV. Geography and access to highly active anti-retroviral therapy (HAART) have a major influence on which of these targets is affected. In sub-Saharan Africa, where tuberculosis is endemic and access to HAART is limited, the dominant forms of HIV-associated heart disease are pericardial tuberculosis and cardiomyopathy. However, in industrialized countries, where tuberculosis is rare and HAART is widely available, coronary artery disease is the main cause of death and disability in these patients. Observational data suggest that HAART, by preserving immune function, reduces the incidence of myopericardial disease and pulmonary hypertension. The result has been that, although optimal strategies to reduce vascular disease in this population continue to be sought and debated in industrialized nations, the focus of prevention and treatment strategies for HIV-related heart disease in developing countries has been to support the active campaigns to get universal access to HAART in the first place. Herein, we review the cardiac manifestations of HIV in sub-Saharan Africa.
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Heart Failure III: Clinical Manifestations
Cryptococcal Meningitis
Endocarditis II: Clinical Features of Infective Endocarditis
Sexually Transmitted Infections
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
